Silexion Therapeutics Corp. (SLXN)
0.3606
-0.03
(-8.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.3602
0.00 (0.00%)
After-Hours: 20:00
Silexion Therapeutics Market Cap : 0.4255M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 0.465M |
| August 20, 2026 | 0.4707M |
| August 19, 2026 | 0.4875M |
| August 18, 2026 | 0.4934M |
| August 17, 2026 | 0.4979M |
| August 14, 2026 | 0.4958M |
| August 13, 2026 | 0.5427M |
| August 12, 2026 | 0.5357M |
| August 11, 2026 | 1.221M |
| August 10, 2026 | 0.469M |
| August 07, 2026 | 0.5847M |
| August 06, 2026 | 0.5597M |
| August 05, 2026 | 0.5629M |
| August 04, 2026 | 0.5941M |
| August 03, 2026 | 0.6098M |
| July 31, 2026 | 0.5879M |
| July 30, 2026 | 0.5754M |
| July 29, 2026 | 0.5003M |
| July 28, 2026 | 0.7661M |
| July 27, 2026 | 0.7911M |
| July 24, 2026 | 0.7098M |
| July 23, 2026 | 0.7442M |
| July 22, 2026 | 0.788M |
| July 21, 2026 | 0.7849M |
| July 20, 2026 | 0.8099M |
| Date | Value |
|---|---|
| July 17, 2026 | 0.8068M |
| July 16, 2026 | 0.8693M |
| July 15, 2026 | 0.8068M |
| July 14, 2026 | 0.7817M |
| July 13, 2026 | 0.7817M |
| July 10, 2026 | 0.8099M |
| July 09, 2026 | 0.8161M |
| July 08, 2026 | 0.8255M |
| July 07, 2026 | 0.8568M |
| July 06, 2026 | 0.8912M |
| July 02, 2026 | 0.8271M |
| July 01, 2026 | 0.8083M |
| June 30, 2026 | 0.7974M |
| June 29, 2026 | 0.8036M |
| June 26, 2026 | 0.8599M |
| June 25, 2026 | 0.8537M |
| June 24, 2026 | 0.8443M |
| June 23, 2026 | 0.8474M |
| June 22, 2026 | 0.8443M |
| June 18, 2026 | 0.8537M |
| June 17, 2026 | 0.9068M |
| June 16, 2026 | 0.8474M |
| June 15, 2026 | 0.8599M |
| June 12, 2026 | 0.9788M |
| June 11, 2026 | 0.9662M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 12.18M |
| XTL Biopharmaceuticals Ltd. | 5.985M |
| Kamada Ltd. | 485.79M |
| Can-Fite BioPharma Ltd. | 4.298M |
| Galmed Pharmaceuticals Ltd. | 3.316M |
Market Cap Related Metrics
| Price to Book Value | 9.669 |
| Price | 0.3606 |
| Earnings Yield | -15.68K% |